A detailed history of Shell Asset Management CO transactions in Organon & Co. stock. As of the latest transaction made, Shell Asset Management CO holds 14,822 shares of OGN stock, worth $218,328. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,822
Previous 15,674 5.44%
Holding current value
$218,328
Previous $324,000 12.35%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$18.65 - $23.03 $15,889 - $19,621
-852 Reduced 5.44%
14,822 $284,000
Q1 2024

Jul 31, 2024

SELL
$13.78 - $18.8 $13,600 - $18,555
-987 Reduced 5.92%
15,674 $324,000
Q1 2024

May 14, 2024

BUY
$13.78 - $18.8 $147,818 - $201,667
10,727 Added 180.77%
16,661 $313,000
Q4 2023

Feb 14, 2024

SELL
$10.95 - $17.32 $19,600 - $31,002
-1,790 Reduced 23.17%
5,934 $86,000
Q3 2023

Nov 08, 2023

SELL
$16.59 - $23.77 $2,023 - $2,899
-122 Reduced 1.55%
7,724 $134,000
Q2 2023

Jul 28, 2023

SELL
$19.27 - $24.63 $867 - $1,108
-45 Reduced 0.57%
7,846 $163,000
Q1 2023

May 15, 2023

SELL
$21.42 - $32.08 $599 - $898
-28 Reduced 0.35%
7,891 $186,000
Q4 2022

Feb 07, 2023

SELL
$23.31 - $28.61 $37,505 - $46,033
-1,609 Reduced 16.89%
7,919 $221,000
Q3 2022

Nov 14, 2022

SELL
$23.4 - $34.25 $58,406 - $85,488
-2,496 Reduced 20.76%
9,528 $223,000
Q2 2022

Aug 09, 2022

BUY
$31.66 - $38.9 $633 - $778
20 Added 0.17%
12,024 $406,000
Q1 2022

May 04, 2022

SELL
$30.45 - $39.36 $54,231 - $70,100
-1,781 Reduced 12.92%
12,004 $419,000
Q4 2021

Feb 09, 2022

BUY
$28.67 - $37.13 $395,215 - $511,837
13,785 New
13,785 $420,000
Q3 2021

Nov 04, 2021

SELL
$28.63 - $35.64 $723,022 - $900,052
-25,254 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$28.45 - $38.0 $718,476 - $959,652
25,254 New
25,254 $764,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.